PubMed HealthSearch

PubMed · 8734538

Second-order texture contrast resolves ambiguous apparent motion.

Abstract

When a black and a white square on a grey surround exchange places, it was previously shown that on a dark surround it is the white square, and on a light surround it is the black square, that is seen in apparent motion (AM). Thus the higher-contrast square carries the AM. We now show that the same is true for second-order AM of texture-defined squares. Squares were defined by four different textures: by anisotropy (horizontal versus vertical random dashes), by alpha numeric letters, by hash marks, or by dot size. The result was that the square that differed more from the surround in texture properties carried the second-order AM. Judgments of texture salience revealed a high correlation between salience and apparent motion. In a third experiment, crossover AM between dissimilar textures was investigated, and it was found that the more salient textures carried the AM. Results cannot be explained by the concept of "texture activity', but instead indicate that the system extracts a measure of "texture contrast' prior to analysis of salience and apparent motion.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Mather, S Anstis. 1995. Second-order texture contrast resolves ambiguous apparent motion.. https://doi.org/10.1068/p241373

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Origin of the residual NMR linewidth of a peptide bound to a resin under magic angle spinning.

The tetrapeptide Ala-lle-Gly-Met bound to a Wang resin via the methionine residue was studied by NMR under MAS conditions and compared to the same peptide in solution. The bound peptide exhibits average linewidths superior to those observed for the peptide in solution. The origin of the residual NMR linewidth observed for the bound form was investigated. The dynamics of the peptide is shown to be only marginally responsible for the increased linewidth; the major cause of the line broadening appears to be nonaveraged magnetic susceptibility differences.

Anisotropy

Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.

Using Monte Carlo methods, neutron dosimetry for 252Cf Applicator Tube (AT) type medical sources available from Oak Ridge National Laboratory (ORNL) has for the first time been determined in terms of TG-43 formalism. This approach, as compared to previous "along-away" formalisms, demonstrates the relative angular independence of dose rate data, when the geometry factor has been removed. As the ORNL-made 252Cf AT type sources are considerably physically larger than most clinical sources used today, the radial dose function increases for radii less than 3.0 mm due to breakdown of the line source model. A comparison of the 252Cf neutron radial dose function with those for other medical sources revealed similarities with that from 137Cs. Differences with respect to previous 252Cf AT source neutron dosimetry data generally increased at increasing distances. This was attributed to differences in the various 252Cf AT source models and phantom compositions. The current status of 252Cf medical source fabrication and calibration procedures at ORNL is presented.

Anisotropy

Protein-protein interactions in the assembly of Shigella flexneri invasion plasmid antigens IpaB and IpaC into protein complexes.

Shigella flexneri is a facultative intracellular bacterial pathogen that invades human colonic epithelial cells by a process called pathogen-induced phagocytosis. Pathogen entry requires three virulence plasmid-encoded proteins called invasion plasmid antigens (Ipa) B, C and D which are secreted upon bacterial contact with a host cell. Following their secretion, IpaB and IpaC are found within a complex of proteins that may also contain IpaA and IpaD. Previous work has shown that exogenously added recombinant IpaC is sufficient for promoting the uptake of S. flexneri in gentamicin-protection assays. It is shown here that purified recombinant Ipa proteins can also be used to investigate the formation of Ipa protein complexes in vitro. The protein-protein contacts involved in the formation of Ipa complexes appear to include previously undescribed IpaC-IpaC interactions in addition to a strong association between IpaB and IpaC. IpaD does not appear to interact with either IpaB or IpaC in vitro although it is possible that recombinant IpaD forms homodimers that are stabilized by disulfide bridges involving this protein's single cysteine residue. This investigation represents the first characterization of the biochemistry of Ipa complex assembly.

Anisotropy